Loading clinical trials...
Loading clinical trials...
A PROSPECTIVE LOW-INTERVENTIONAL PHASE 4 SINGLE ARM STUDY OF OCULAR ASSESSMENTS IN PATIENTS TREATED WITH TIVDAK® IN RECURRENT OR METASTATIC CERVICAL CANCER
Conditions
Interventions
TIVDAK
Locations
93
United States
HonorHealth Cancer Care - Biltmore - AZCCC Imaging
Phoenix, Arizona, United States
HonorHealth Cancer Care - Biltmore - HonorHealth Research Pharmacy
Phoenix, Arizona, United States
Sonora Quest Laboratories, LLC
Phoenix, Arizona, United States
South West Medical Imaging (SMIL)
Phoenix, Arizona, United States
Schwartz Laser Eye Center
Scottsdale, Arizona, United States
Virginia G. Piper Cancer Pharmacy - HonorHealth Research Pharmacy
Scottsdale, Arizona, United States
Start Date
May 7, 2025
Primary Completion Date
December 13, 2028
Completion Date
December 13, 2028
Last Updated
April 20, 2026
NCT06157151
NCT04895709
NCT05108298
NCT05952141
NCT07276360
NCT04226313
Lead Sponsor
Pfizer
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions